SCHEMBL24977190

SCHEMBL24977190

COCCn1ccc(S(=O)(=O)Cl)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.35
SCN9A Q15858 1/20 0.34
AR P10275 1/20 0.33
HTR1A P08908 1/20 0.32
HTR2A P28223 1/20 0.32
HTR7 P34969 1/20 0.32
HTR6 P50406 1/20 0.32
ALDH1A1 P00352 5/20 0.32
MAP4K4 O95819 1/20 0.32
EGFR P00533 1/20 0.32
FRK P42685 1/20 0.32
MAPK9 P45984 1/20 0.32
CSNK1D P48730 1/20 0.32
SLK Q9H2G2 1/20 0.32
KDM4E B2RXH2 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
ATM Q13315 1/20 0.32
MAPT P10636 1/20 0.31
PABPC1 P11940 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22497220 0.84 CA2 (0.36) MPOSCN9AARHTR1AHTR2A
SCHEMBL21962212 0.78 HDAC3 (0.49) ALDH1A1GAASMN1; SMN2MEN1KMT2A
SCHEMBL20757795 0.78 CYP1A2 (0.39) ALDH1A1GAAMAPTSMN1; SMN2HSD17B10
SCHEMBL20743234 0.74 ALDH1A1 (0.31) ALDH1A1HSD17B10
SCHEMBL26453198 0.74 MAP4K4 (0.37) MPOARALDH1A1MAP4K4EGFR
SCHEMBL22524841 0.73 IGF1R (0.31) ALDH1A1PABPC1HPGDSMN1; SMN2HSD17B10
SCHEMBL18029743 0.72 TERT (0.36) ALDH1A1MAPTKMT2A
SCHEMBL13242164 0.72 THRB (0.40) MPOHTR2AALDH1A1MAP4K4EGFR
SCHEMBL20552 0.71 KMT2A (0.38) HTR6ALDH1A1KDM4EMAPTHPGD
SCHEMBL1079285 0.70 ALDH1A1 (0.42) MPOHTR1AHTR2AHTR7HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-18 US disclosed
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-18 US disclosed
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators GLOBAL BLOOD THERAPEUTICS, INC. (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11566030-B2 Substituted 2,6-dihydropyrrolo[3,4-c]pyrazoles as pyruvate kinase activators PDK1, PDK2, PDK3 MPO 3852/4885SCN9A 3179/4885AR 3139/4885
US-20230151016-A1 PYRROLIDINE-PYRAZOLES AS PYRUVATE KINASE ACTIVATORS PDK1, PDK2, PKM MPO 3079/4885SCN9A 2761/4885AR 3857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.